Karo Pharma AB buy Raymond James
Start price
24.07.25
/
50%
€5.44
Target price
24.07.26
€50.96
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 24.07.26. The prediction end date can be changed by Raymond_James at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Karo Pharma AB | - | - |
| iShares Core DAX® | -3.986% | -2.814% |
| iShares Nasdaq 100 | 0.345% | -0.748% |
| iShares Nikkei 225® | -3.853% | 4.229% |
| iShares S&P 500 | 0.298% | 0.379% |
Comments by Raymond_James for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Ratings data for KARO provided by MarketBeat